Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dexpanthenol
Drug ID BADD_D00632
Description Dexpanthenol is an alcohol derivative of pantothenic acid, a component of the B complex vitamins and an essential component of a normally functioning epithelium. Dexpanthenol is enzymatically cleaved to form pantothenic acid, which is an essential component of Coenzyme A, which acts as a cofactor in many enzymatic reactions that are important for protein metabolism in the epithelium[A32373]. Due to its good penetration and high local concentrations, dexpanthanol is used in many topical products, such as ointments and lotions for treatment of dermatological conditions to relieve itching or promote healing. Dermatological effects of the topical use of dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties [A32377]. Dexpanthenol is also available as a racemic mixture containing both the dextrorotatory form (dexpanthenol) and the levorotatory form (levopanthenol) as [DB11204]. While pantothenic acid is optically active, only the dextrorotatory form (dexpanthenol) is biologically active.
Indications and Usage Injection: Prophylactic use immediately after major abdominal surgery to minimize the possibility of paralytic ileus. Intestinal atony causing abdominal distention; postoperative or postpartum retention of flatus, or postoperative delay in resumption of intestinal motility; paralytic ileus. Topical: This medication is used as a moisturizer to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations (e.g., diaper rash, skin burns from radiation therapy).
Marketing Status approved
ATC Code A11HA30; D03AX03; S01XA12
DrugBank ID DB09357
KEGG ID D00193
MeSH ID C007288
PubChem ID 131204
TTD Drug ID D0H9ZQ
NDC Product Code 51552-1581; 48041-0003; 63238-3110; 90027-014; 73519-001
UNII 1O6C93RI7Z
Synonyms dexpanthenol | D-panthenol | (+)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide | Dexpanthenol Heumann | Panthenol-ratiopharm | Ilopan | Marolderm | NasenSpray ratiopharm Panthenol | Nasicur | Otriven Dexpanthenol | Pan-Ophtal | Panthenol Braun | Panthenol Jenapharm | Panthenol LAW | Panthenol Lichtenstein | panthenol von ct | Bepanthen | Panthoderm | Panthogenat | Pan Rhinol | Rhinoclir | Ucee D | Urupan | Wund- und Heilsalbe LAW | panthenol | pantothenol | 2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide | Corneregel | DL-panthenol | butanamide, 2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethyl-, (+--)- | Repa-Ophtal | Siozwo SANA
Chemical Information
Molecular Formula C9H19NO4
CAS Registry Number 81-13-0
SMILES CC(C)(CO)C(C(=O)NCCCO)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Agitation17.02.05.012; 19.06.02.001--
Dermatitis23.03.04.002---
Diarrhoea07.02.01.001--
Dyspnoea02.11.05.003; 22.02.01.004--
Hypersensitivity10.01.03.003--
Hypotension24.06.03.002--
Paraesthesia17.02.06.005; 23.03.03.094--
Pruritus23.03.12.001--
Urticaria10.01.06.001; 23.04.02.001--
Vomiting07.01.07.003--
The 1th Page    1    Total 1 Pages